Uracil/tegafur plus oral calcium folinate in advanced breast cancer

Autor: Richardet, Eduardo Arnoldo, Pedraza, Cecilia, Mickiewicz, Elizabeth, Lerzo, Guillermo, Bonamasa, Miguel, Coppola, Federico, Elli, Alicia, Uranga, Graciela, Jovtis, Silvia, Bruno, Mario, Ventriglia, Mónica, Cuevas, María Andrea

Publikováno v: Richardet, Eduardo Arnoldo, Pedraza, Cecilia, Mickiewicz, Elizabeth, Lerzo, Guillermo, Bonamasa, Miguel, Coppola, Federico, Elli, Alicia, Uranga, Graciela, Jovtis, Silvia, Bruno, Mario, Ventriglia, Mónica and Cuevas, María Andrea (1999) Uracil/tegafur plus oral calcium folinate in advanced breast cancer. Oncology, 13 (7). pp. 96-97. ISSN 0890-9091
Producción Académica (UCC)
Universidad Católica de Córdoba
instacron:UCC

Uracil and tegafur (in a molar ratio of 4:1 [UFT]) has proven activity against breast cancer and is delivered in an easy-to-administer oral formulation. Orzel, which combines UFT with the oral biomodulator, calcium folinate, may provide even greater

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a346b5581a30eebd688f6e88f981fc06
http://pa.bibdigital.ucc.edu.ar/3734/

Phase II Study of Gemcitabine, 5-Fluorouracil, and Leucovorin in Patients With Pancreatic Cancer

Autor: Marantz, Adolfo, Jovtis, Silvia, Almira, Eduardo, Balbiani, Luis, Castilla, José Luis, Fein, Luis, Lewi, Daniel, Pasccon, Graciela, Pinckevicius, Roberto, Uranga, Graciela, Abal, Mariana, Muiño, Marcelo, Reale, Mónica, Agusto, Silvia, Lastiri, Francisco

Publikováno v: Seminars in Oncology; June 2001, Vol. 28 Issue: 9 p44-49, 6p